Alejandro C. Arroliga, MD Director, Medical Intensive Care Unit, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic
Raed A. Dweik, MD Department of Pulmonary and Critical Care Medicine, Cleveland Clinic
F. J. Takao Kaneko, MD Department of Critical Care Medicine, Central Military Hospital, Mexico City, Mexico
Serpil C. Erzurum, MD Department of Pulmonary and Critical Care Medicine, Cleveland Clinic
Address: Alejandro C. Arroliga, MD, Medical Intensive Care Unit, G62, Cleveland Clinic, 9500 Euclid Avenue, Cleveland OH 44195; arrolia@ccf.org
ABSTRACT
Primary pulmonary hypertension is a progressive and fatal disease that chiefly affects young adults. Although its etiology is a mystery, recent research has uncovered several biochemical derangements in this disorder, and new therapies are prolonging survival.
